Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
EMCURE PHARMACEUTICALS IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
EMCURE PHARMACEUTICALS Limited Financial Information (Restated Consolidated)
Amount in (₹ in Millions)
| Period Ended | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|
| Reserve of Surplus | 27,711.31 | 23,202.74 | 18,066.96 |
| Total Assets | 78,061.63 | 66,725.31 | 60,634.69 |
| Total Borrowings | 20,919.35 | 22,024.21 | 21,021.90 |
| Fixed Assets | 19,485.73 | 16,046.34 | 14,702.77 |
| Cash | 1,690.00 | 2,423.42 | 1,628.49 |
| Cash flow from operating activities | |||
| Cash flows from investing activities | |||
| Cash flow from financing activities | |||
| Net Borrowing | 1,9229.35 | 19,600.79 | 19,393.41 |
| Revenue | 67,152.41 | 60,317.16 | 59,188.60 |
| EBITDA | 12,767.82 | 12,209.41 | 13,933.81 |
| PAT | 5,275.75 | 5,618.45 | 7,025.56 |
| PAT Margin | |||
| EPS | 27.54 | 29.42 | 36.63 |
Note 1:- ROCE & ROE calculation in KPI is based on 31st DMar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after completion of Offer Price.
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
